Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Epidermal growth factor receptor (EGFR) signaling and covalent EGFR inhibition in lung cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 20 Sept 2012

Heuckmann Johannes M, Rauh Daniel, Thomas Roman K

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Mutation
Share to Adenocarcinoma
Share to Carcinoma, Non-Small-Cell Lung
Share to Drug Resistance, Neoplasm

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to Lung Neoplasms

Share to Protein Kinase Inhibitors

Share to Signal Transduction

Source

Identifiers

PMID: 22915655
DOI: 10.1200/JCO.2012.43.1825

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 10 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Epidermal growth factor receptor (EGFR) signaling and covalent EGFR inhibition in lung cancer.PMID 22915655Read ↗

EGFR mutations and molecularly targeted therapy: a new era in the treatment of lung cancer.Semantic proximity Read ↗

Molecular targeted therapy of lung cancer: EGFR mutations and response to EGFR inhibitors.Semantic proximity Read ↗

EGFR mutations and EGFR tyrosine kinase inhibitors.Semantic proximity Read ↗

Deregulated EGFR signaling during lung cancer progression: mutations, amplicons, and autocrine loops.Semantic proximity Read ↗

Lung cancer in 'never-smokers': beyond EGFR mutations and EGFR-TK inhibitors.Semantic proximity Read ↗

Personalized Medicine and Inhibition of<i>EGFR</i>Signaling in Lung CancerSemantic proximity Read ↗

The evolving story of the epidermal growth factor receptor as a target for non-small-cell lung cancer.Semantic proximity Read ↗

Covalent EGFR Inhibitors: Binding Mechanisms, Synthetic Approaches, and Clinical Profiles.Semantic proximity Read ↗

Signaling pathways modulating dependence of lung cancer on mutant epidermal growth factor receptor and mechanisms of intrinsic and acquired resistance to tyrosine kinase inhibitors.Semantic proximity Read ↗

Epigenetic targeting of DNA repair in lung cancer.Semantic proximity Read ↗

Crossing the rubicon in lung adenocarcinoma: the conundrum of EGFR tyrosine kinase mutations.Semantic proximity Read ↗

Adjuvant Targeted Therapy for Patients With Epidermal Growth Factor Receptor-Mutant Lung Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.